ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $694 | -100.0% | 33,304 | -39.3% | 0.04% | -62.0% |
| Q4 2020 | $2,934,000 | +28.6% | 54,880 | -0.7% | 0.10% | +33.3% |
| Q3 2020 | $2,281,000 | -16.7% | 55,280 | -2.1% | 0.08% | 0.0% |
| Q2 2020 | $2,737,000 | -46.5% | 56,470 | -53.4% | 0.08% | -51.0% |
| Q1 2020 | $5,113,000 | -3.9% | 121,051 | -2.7% | 0.15% | +25.4% |
| Q4 2019 | $5,320,000 | -9.1% | 124,370 | -23.5% | 0.12% | -6.9% |
| Q3 2019 | $5,851,000 | +477.0% | 162,566 | +348.4% | 0.13% | +322.6% |
| Q1 2016 | $1,014,000 | – | 36,254 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |